Sort
326,823 grants matching “clinical trial”
Population Genetics Analysis Program: Immunity to Vaccines and Infections
$2,087,937Richard A. Kaslow · University Of Alabama At Birmingham · N01 · FY2010 · AI
Duke SPORE in Brain Cancer
$2,087,874John H Sampson · Duke University · P50 · FY2019 · CA
Immunopathogenesis of Acute HIV-1 Infection
$2,087,864Elizabeth Connick · University Of Colorado Denver · P01 · FY2007 · AI
Duke SPORE in Brain Cancer
$2,087,855David M. Ashley · Duke University · P50 · FY2023 · CA
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,087,820Stanford University · P01 · FY2002 · CA
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
$2,087,709Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · AI
Philadelphia IMPAACT Clinical Trials Unit
$2,087,680Steven Daniel Douglas · Children'S Hosp Of Philadelphia · U01 · FY2010 · AI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY
$2,087,525Joel M Friedman · Albert Einstein College Of Medicine · P01 · FY2014 · HL
Clinical & Research Informatics
$2,087,423Asma Idriss · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIH · FY2025 · HD
Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)
$2,086,730Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2023 · CA
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center
$2,086,717Peter D. Friedmann · Baystate Medical Center, Inc. · UG1 · FY2019 · DA
Duke SPORE in Brain Cancer
$2,086,695David M. Ashley · Duke University · P50 · FY2022 · CA
Integrative Oncogenomics of Multiple Myeloma
$2,086,676Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2017 · CA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,086,388University Of North Carolina Chapel Hill · U01 · FY2003 · AI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$2,086,208Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2012 · GM
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines
$2,086,176Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
PIDTC Administrative Unit
$2,086,129Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2022 · AI
Advancing the Development of a Humanized Anti-cocaine Monoclonal Antibody
$2,086,019Andrew B Norman · University Of Cincinnati · U01 · FY2017 · DA
Neuroprotection Studies in PD: A Coordinating Center
$2,085,990Karl D. Kieburtz · University Of Rochester · U01 · FY2007 · NS
Epithelial Ovarian Cancer Program Project
$2,085,988David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Cooperative Multicenter Diabetes Research Network for Hypoglycemia Prevention
$2,085,961Roy W Beck · Jaeb Center For Health Research, Inc. · U10 · FY2009 · HD
Medical University of South Carolina - Cancer Center Support Grant
$2,085,771Denis C Guttridge · Medical University Of South Carolina · P30 · FY2019 · CA
Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses
$2,085,765Garth Powis · Phusis Therapeutics, Inc. · R44 · FY2025 · CA
The ISCHEMIA Trial - SDCC
$2,085,736Sean M O'Brien · Duke University · U01 · FY2014 · HL
Antecedent Biomarkers For AD: The Adult Children Study
$2,085,733John Morris · Washington University · P01 · FY2018 · AG